Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients

BACKGROUND: Cardiac autonomic neuropathy (CAN) in diabetes is among the strongest risk markers for future global and cardiovascular mortality. The aim of this study was to analyse CAN prevalence and to compare the associations between CAN, the glycaemic control, cardiovascular risk factors, peripher...

Descripción completa

Detalles Bibliográficos
Autores principales: Moţăţăianu, Anca, Maier, Smaranda, Bajko, Zoltan, Voidazan, Septimiu, Bălaşa, Rodica, Stoian, Adina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112121/
https://www.ncbi.nlm.nih.gov/pubmed/30149797
http://dx.doi.org/10.1186/s12883-018-1125-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112121/
https://www.ncbi.nlm.nih.gov/pubmed/30149797
http://dx.doi.org/10.1186/s12883-018-1125-1

Ejemplares similares